LY75-CD302

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, LY75-CD302 mutation is significantly associated with the RNA expression of many other genes, with 46 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible LY75-CD302-associated genes across cancer lineages are ATRIP, ALKBH5, and TOX4. Each is linked with LY75-CD302 in more than 1 cancer types. Because this analysis shows association rather than direction, both LY75-CD302-to-partner and partner-to-LY75-CD302 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, ATRIP grouped by LY75-CD302-low versus LY75-CD302-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (LY75-CD302→partner) and Y-score (partner→LY75-CD302) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECATRIP →+0.220+3.354<.001.00731
UCECALKBH5 →+0.559+3.242.007.00931
UCECTOX4 →+0.531+3.201.006.00931
UCECHARBI1 →+0.528+3.201.002.00931
UCECTM2D3 →+0.511+3.210.004.00931
UCECRNU1-17P →+0.325+3.350<.001.00131
Each partner links to its Q-omics profile. Showing the 6 strongest of 46 associations by consensus.

ATRIP by LY75-CD302 expression — UCEC

Box plot of ATRIP in LY75-CD302-low vs LY75-CD302-high samples in UCEC.

Explore this box plot interactively →

Exploration